Neurophysiological characteristics of MuSK antibody positive Myasthenia Gravis mice: Focal denervation and hypersensitivity to acetylcholinesterase inhibitors

Journal of the Neurological Sciences

Volumn 316, Issue 1-2, 2012, Pages 150-157

  Chroni, Elisabeth ^a   Punga, Anna Rostedt ^b  

^a UNIVERSITY OF PATRAS   (Greece)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acetylcholinesterase inhibitors; Denervation; EMG; MuSK; Myasthenia; Neuromuscular transmission

Indexed keywords

NEOSTIGMINE; PROTEIN MUSK; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FACE MUSCLE; FEMALE; GASTROCNEMIUS MUSCLE; HYPERSENSITIVITY; MASSETER MUSCLE; MOUSE; MYASTHENIA GRAVIS; NERVE STIMULATION; NEUROMUSCULAR TRANSMISSION; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOANTIBODIES; CHOLINESTERASE INHIBITORS; DENERVATION; FEMALE; MASSETER MUSCLE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; NEUROMUSCULAR JUNCTION; RANDOM ALLOCATION; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84859442819     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2011.12.016     Document Type: Article

References (27)

1. M.E. Farrugia, M.D. Robson, L. Clover, P. Anslow, J. Newsom-Davis, and R. Kennett MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis Brain 129 2006 1481 1492
2. V. Zouvelou, M. Rentzos, P. Toulas, and I. Evdokimidis MRI Evidence of Early Muscle Atrophy in MuSK Positive Myasthenia Gravis J Neuroimaging 21 2011 303 305
3. J.T. Guptill, D.B. Sanders, and A. Evoli Anti-musk antibody myasthenia gravis: Clinical findings and response to treatment in two large cohorts Muscle Nerve 44 2011 36 40
4. S.J. Oh, Y. Hatanaka, S. Hemmi, A.M. Young, M.L. Scheufele, and S.P. Nations Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis Muscle Nerve 33 2006 500 504
5. D.B. Sanders, and E.V. Stalberg AAEM minimonograph #25: single-fiber electromyography Muscle Nerve 19 1996 1069 1083
6. D.B. Sanders, K. El-Salem, J.M. Massey, J. McConville, and A. Vincent Clinical aspects of MuSK antibody positive seronegative MG Neurology 60 2003 1978 1980
7. A. Evoli, P.A. Tonali, L. Padua, M.L. Monaco, F. Scuderi, and A.P. Batocchi Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis Brain 126 2003 2304 2311
8. A.R. Punga, R. Flink, H. Askmark, and E.V. Stalberg Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody Muscle Nerve 34 2006 111 115
9. A.R. Punga, M. Sawada, and E.V. Stalberg Electrophysiological signs and the prevalence of adverse effects of acetylcholinesterase inhibitors in patients with myasthenia gravis Muscle Nerve 37 2008 300 307
10. C.C. Chang, S.J. Hong, and J.L. Ko Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm Br J Pharmacol 87 1986 757 762
11. S. Jha, K. Xu, T. Maruta, M. Oshima, D.R. Mosier, and M.Z. Atassi Myasthenia gravis induced in mice by immunization with the recombinant extracellular domain of rat muscle-specific kinase (MuSK) J Neuroimmunol 175 2006 107 117
12. K. Xu, S. Jha, W. Hoch, and S.E. Dryer Delayed synapsing muscles are more severely affected in an experimental model of MuSK-induced myasthenia gravis Neuroscience 143 2006 655 659
13. O. Benveniste, L. Jacobson, M.E. Farrugia, L. Clover, and A. Vincent MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo J Neuroimmunol 170 2005 41 48
14. A.R. Punga, S. Lin, F. Oliveri, S. Meinen, and M.A. Ruegg Muscle-selective synaptic disassembly and reorganization in MuSK antibody positive MG mice Exp Neurol 230 2011 207 217
15. J.R. Sheng, L. Li, B.B. Ganesh, C. Vasu, B.S. Prabhakar, and M.N. Meriggioli Suppression of experimental autoimmune myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3 + regulatory T cells J Immunol 177 2006 5296 5306
16. J.R. Sheng, L.C. Li, B.B. Ganesh, B.S. Prabhakar, and M.N. Meriggioli Regulatory T cells induced by GM-CSF suppress ongoing experimental myasthenia gravis Clin Immunol 128 2008 172 180
17. P.W. Berman, and J. Patrick Experimental myasthenia gravis. A murine system J Exp Med 151 1980 204 223
18. L.M. Tagliari, and A-d-PW Tetanic fade induced by d-Tubocurarine, Hexamethonium and Neostigmine in phrenic nerve diaphragm of diabetic rats Acta Sci 20 1986 231 234
19. P. Scotton, D. Bleckmann, M. Stebler, F. Sciandra, A. Brancaccio, and T. Meier Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin J Biol Chem 281 2006 36835 36845
20. M.N. Meriggioli, and D.B. Sanders Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity Lancet Neurol 8 2009 475 490
21. A. Vincent, and M.I. Leite Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis Curr Opin Neurol 18 2005 519 525
22. R. Besser, L. Gutmann, U. Dillmann, L.S. Weilemann, and H.C. Hopf End-plate dysfunction in acute organophosphate intoxication Neurology 39 1989 561 567
23. J.G. van Dijk, G.J. Lammers, A.R. Wintzen, and P.C. Molenaar Repetitive CMAPs: mechanisms of neural and synaptic genesis Muscle Nerve 19 1996 1127 1133
24. A.R. Punga, M. Maj, S. Lin, S. Meinen, and M.A. Ruegg MuSK levels differ between adult skeletal muscles and influence postsynaptic plasticity Eur J Neurosci 33 2011 890 898
25. A. Evoli, M.R. Bianchi, R. Riso, G.M. Minicuci, A.P. Batocchi, and S. Servidei Response to therapy in myasthenia gravis with anti-MuSK antibodies Ann N Y Acad Sci 1132 2008 76 83
26. Y. Hatanaka, S. Hemmi, M.B. Morgan, M.L. Scheufele, G.C. Claussen, and G.I. Wolfe Nonresponsiveness to anticholinesterase agents in patients with MuSK-antibody-positive MG Neurology 65 2005 1508 1509
27. M. Scheller, J. Bufler, I. Hertle, H.J. Schneck, C. Franke, and E. Kochs Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state Anesth Analg 83 1996 830 836